Clinical trial
Leridistim Compared With Filgrastim in Treating Older Patients With Acute…
NCT00004215 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004215 |
|---|---|
| Title | Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia |
| Official title | Clinical Protocol for a Phase II Study of Leridistim (SC-70935) in Adult Patients (Age>55) With Acute Myeloid Leukemia (AML) Receiving Chemotherapy With the Cytarabine and Daunorubicin "7+3" Regimen |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Leukemia, Neutropenia, Thrombocytopenia |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, leridistim, cytarabine, daunorubicin hydrochloride |
| Start date | Aug 1, 1999 |
| Primary completion | Aug 1, 2000 |
| Completion | Aug 1, 2000 |
| First posted | Aug 9, 2004 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: